Sagar V. Parikh, MD, overviews the potential benefits of pharmacogenomic testing for antidepressant selection, which can offer insights into the tolerability and efficacy of the therapies on an individual...
Larry Smarr, Founding Director, CALIT2, details the growing epidemic of children, especially those with gastrointestinal disorders, who were not exposed to the necessary microbiomes during the formative...
